We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 1996
Laporte has sold its European adhesives operation to Elf of France for about £100m.
Yule Catto is acquiring PFW Aroma Chemicals in the Netherlands from Hercules of the US for £21m.
Glaxo Wellcome is acquiring full control of Nippon Glaxo, its joint venture with Shin Nihon Jitsugyo, for £360m.
Allied Colloids has acquired CPS, the US producer of water-soluble polymers, for £230m.
Hickson International has sold its Hickson Manro business to Broomco, a new company that includes some managers from Manro, for £26.5m, as part of its debt reduction programme.
Morgan Crucible has acquired EM Corporation, the lubricants supplier, from Great Lakes Chemical Corp for £16m.
Ellis & Everard has acquired Chemitrade, the Manchester-based distributor of solvents, for £7.4m.
Lawter International of the US is acquiring the resin division of Wolstenholme International for £5.5m.
Quintiles of the US is to acquire Innovex, the UK pharmaceutical industry consultancy, for £500m.
Astra of Sweden is to set up a £62m pharmaceuticals research centre in Loughborough, with the creation of about 200 new jobs.
BTR has sold its controlling stakes in three Taiwanese plastics joint ventures to a consortium comprising Union Petrochemical and USI Far East Corporation, for £191m.
Oxford Biomedica, the gene-therapy concern, is planning a public share offer in November in order to raise £5m for the funding of a lease on a site in Oxford and the recruitment of up to 30 staff.
Plascon of South Africa is acquiring Courtaulds' Taubmans architectural coatings operation in Australia for £17m.
Hodgson Chemicals, the BTP subsidiary, has acquired ICI Surfactants' US-based textile operation for $2.3m.
European Colour is to buy Tor, the specialist coatings maker, for £13m.
Inspec is acquiring Shell's Fine Chemicals business for £200m, with the help of a £101m rights issue.
Reckitt & Colman has sold its 80% stake in Globo SA Tintas e Pigmentos, the Brazilian paints and coatings concern, to Bayer for £48m.
Laporte has disposed of more non-core businesses for a total £23m, including the process chemicals business Gramos, the cleanroon garments operation Countdown Clean Systems, the US pet litter business Waverly Minerals, and its 50% stake in Laporte (Malaysia).
Meconic is buying Phoenix Chemicals, the contract manufacturer, for up to £12m.
Quintiles, the US pharmaceutical research company, is to set up a clinical data management service plant in West Lothian, creating up to 300 jobs.
Celltech is selling Celltech Biologicals to Alusuisse-Lonza of Switzerland for £50m.
Doeflex is acquiring BTP's industrial polymers operation for about £6m.
Appryl, the Elf-BP joint venture, is planning a £100m 300,000 tonnes per year polypropylene plant in Grangemouth, creating up to 200 jobs.
Medeva is buying some former Fisons businesses from Rhone-Poulenc Rorer for £263m, including Rochester, which is made up of Fison's former US headquarters and ten branded drugs.
W Canning, the speciality chemicals concern, has bought Amco Sari, a company that sells combustion improvement additives in France, for £2.1m.
Ellis & Everard is acquiring Giltrain Plastics, the Yorkshire-based supplier of polymers, for £4.15m.
Centeon, the US-based joint venture between Hoechst and Rhone-Poulenc Rorer, is to buy Delta Biotechnology, the Nottingham-based maker of human proteins, from BOC for £30m.
BASF is buying Zeneca's textile colours operation for up to £150m, which includes sites in Ellesmere Port, Brazil and North Carolina.
Hanson has sold its Seven Seas vitamin supplements business to Merck of Germany for £150m.
Huntsman of the US is to more than double polystyrene production at its Carrington plant near Manchester, creating 30 jobs, as part of a major worldwide investment programme.
Enron Europe has bought ICI's 50% share in their joint venture, Teesside Gas Transportation, for an undisclosed sum.
Elan of Ireland has announced a $600m merger with Athena Neurosciences, the Californian biotechnology concern.
Skyepharma plans to raise £140m on the market to acquire Jago Holdings, the Swiss drug delivery concern.
Zeneca has sold its speciality inks business to Sun Chemical for £40m and is discussing the sale of its textile dyes operation.
Inspec has acquired a polyimide fibres operation from Lenzing of Austria for £5.7m.
ICI is buying Bunge, the South American paints concern, for $390m, its first major acquisition in South America.
Morgan Crucible has bought a 80% stake in Magna Industrial Company, the Hong Kong-based speciality chemicals concern.
Klinge Pharma has bought Ribosepharm, Medeva's cancer products business in Germany, for £54m.
Inspec has acquired a speciality chemical company in the US with plants in Arizona and Kansas, for $29m from Allied Signal.
Harrisons & Crosfield has acquired Daniel Products, the US maker of chemicals for coatings, for $30m.
ICI Explosives is acquiring a 51% stake in Ibernobel of Spain.
Ellis & Everard has acquired George Mann, the US distributor of caustic soda, bleach and chlorine, and Surphos Chemicals, the Benelux surfactants and phosphates distributor.
Brent Chemicals has sold its industrial chemicals activities in Asia to Chemetall, as part of its simplification programme.
BTR has sold its minority stake in Titan, the Malaysian petrochemical concern, for £89m.
Hickson International has sold Hickson Kerley, the US performance chemical operation, to Tessenderlo of Belgium.